Data / Drug companies / Nuvicare LLC
Nuvicare LLC: 45 products in the FDA NDC directory, labeler code 84324
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Nuvicare LLC (labeler code 84324) lists 45 products in the FDA National Drug Code Directory, covering 26 finished drugs by generic name. By type: 45 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 10, 2026.
The request: Watch Nuvicare LLC (FDA labeler code 84324): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 84324
- Products in commercial distribution
- 45
- Packages
- 45
- Finished drugs by generic name
- 26
- Prescription products
- 0
- Over the counter products
- 45
- Flagged as original packager
- 45 of 45 products that carry the flag
- Started marketing in the last 12 months
- 15
- Earliest marketing start
- July 17, 2024
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 31 | 68.9% |
| Generic drugs (ANDA) | 12 | 26.7% |
| Other unapproved drugs | 2 | 4.4% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 45 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 27 | 60% |
| Capsule, liquid filled | 13 | 28.9% |
| Kit | 2 | 4.4% |
| Tablet, extended release | 2 | 4.4% |
| Tablet, coated | 1 | 2.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Nuvicare-Urinary Tract Defense | 84324-041 | Tablet | Other unapproved drugs | August 10, 2026 |
| Nuvicare-Urinary Pain Relief Maximum Strength | 84324-042 | Tablet | Other unapproved drugs | August 4, 2026 |
| Pain Relief Acetaminophen 325 mg | 84324-046 | Tablet | Over the counter monograph drugs | July 30, 2026 |
| Fexofenadine Hydrochloride | 84324-045 | Tablet | Generic drugs (ANDA) | July 30, 2026 |
| Ibuprofen | 84324-039 | Tablet | Generic drugs (ANDA) | July 29, 2026 |
| Ibuprofen | 84324-038 | Tablet | Generic drugs (ANDA) | July 29, 2026 |
| Acetaminophen, Dextromethorphan HBr | 84324-036 | Capsule, liquid filled | Over the counter monograph drugs | June 17, 2026 |
| Allergy Relief | 84324-040 | Tablet | Generic drugs (ANDA) | May 22, 2026 |
| Nuvicare Long-Acting Cough Relief | 84324-037 | Capsule, liquid filled | Over the counter monograph drugs | March 24, 2026 |
| Bisacodyl | 84324-132 | Tablet, coated | Over the counter monograph drugs | March 2, 2026 |
| Mucus Relief DM | 84324-035 | Tablet | Over the counter monograph drugs | February 2, 2026 |
| Maximum Strength Senna Laxative | 84324-033 | Tablet | Over the counter monograph drugs | January 22, 2026 |
| Nuvicare Hives Relief | 84324-031 | Tablet | Generic drugs (ANDA) | January 21, 2026 |
| Mucus Relief | 84324-026 | Tablet, extended release | Generic drugs (ANDA) | December 16, 2025 |
| Mucus Relief | 84324-034 | Tablet, extended release | Generic drugs (ANDA) | December 4, 2025 |
| Nuvicare-Allergy Relief Loratadine Tablets, 10 mg | 84324-027 | Tablet | Generic drugs (ANDA) | July 1, 2025 |
| Upset Stomach Relief-Bismuth Subsalicylate 262 mg | 84324-028 | Capsule, liquid filled | Over the counter monograph drugs | June 25, 2025 |
| Senna-S Softgel | 84324-030 | Capsule, liquid filled | Over the counter monograph drugs | June 24, 2025 |
| Allergy Relief Diphenhydramine HCl 25mg SoftGel | 84324-029 | Capsule, liquid filled | Over the counter monograph drugs | June 24, 2025 |
| Nuvicare DayTime and NightTime Cold and Flu | 84324-025 | Kit | Over the counter monograph drugs | June 9, 2025 |
| Nuvicare NightTime Cold and Flu Softgel | 84324-024 | Capsule, liquid filled | Over the counter monograph drugs | June 9, 2025 |
| Nuvicare DayTime Cold and Flu Softgel | 84324-023 | Capsule, liquid filled | Over the counter monograph drugs | June 9, 2025 |
| Nuvicare DayTime and NightTime Cold and Flu | 84324-020 | Kit | Over the counter monograph drugs | June 9, 2025 |
| Fexofenadine hydrochloride | 84324-008 | Tablet | Generic drugs (ANDA) | June 9, 2025 |
| Allergy Relief | 84324-001 | Tablet | Generic drugs (ANDA) | June 9, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.